PRF Technologies Ltd. (PRFX) vs XORTX Therapeutics Inc. (XRTX)

A side-by-side comparison of PRF Technologies Ltd. and XORTX Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PRFX vs XRTX

growth of $100 · dividends reinvested · last 6y
PRFX -100.0% (-72.4%/yr)XRTX -97.3% (-45.3%/yr)XRTX compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $100202120222023202420252026$0$3
PRFX XRTX

PRFX vs XRTX: by the numbers

  • •XRTX is the larger company ($481786 vs $70884 market cap).
  • •Both run net losses; XRTX's is the smaller (0.00% vs -22521.52% net margin).

Metrics side by side

Valuation

MetricPRFXXRTX
P/S ratio1.79N/A
P/B ratio0.000.09

Profitability

MetricPRFXXRTX
Gross margin-4864.71%0.00%
Operating margin-29335.29%0.00%
Net margin-22521.52%0.00%
ROE-56.04%-68.17%
ROIC-53.95%-71.43%

Growth (annualized)

MetricPRFXXRTX
Total return CAGR (5Y)-74.50%-63.52%

Frequently asked

How have PRFX and XRTX total returns compared?
Over the past 5 years, PRFX delivered -74.50% and XRTX delivered -63.52% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.